Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis

被引：57

作者：

Ohyashiki, K

Kuriyama, Y

Nakajima, A

Tauchi, T

Ito, Y

Miyazawa, K

Kimura, Y

Serizawa, H

Ebihara, Y

机构：

[1] Tokyo Med Univ, Dept Internal Med 1, Shinjuku Ku, Tokyo 1600023, Japan

[2] Tokyo Med Univ, Div Surg Pathol, Tokyo 1600023, Japan

来源：

LEUKEMIA | 2002年 / 16卷 / 10期

关键词：

D O I：

10.1038/sj.leu.2402702

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：2160 / 2161

页数：2

共 7 条

[1]

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[2]

Elliott MA, 2002, NEW ENGL J MED, V346, P712

[3]

Chronic myeloid leukemia: current treatment options [J].

Goldman, JM ;

Druker, BJ .

BLOOD, 2001, 98 (07) :2039-2042

[4]

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. [J].

Kantarjian, H ;

Sawyers, C ;

Hochhaus, A ;

Guilhot, F ;

Schiffer, C ;

Gambacorti-Passerini, C ;

Niederwieser, D ;

Resta, D ;

Capdeville, R ;

Zoellner, U ;

Talpaz, M ;

Druker, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :645-652

[5]

Imatinib mesylate: Clinical results in Philadelphia chromosome-positive leukemias [J].

Kantarjian, HM ;

Talpaz, M .

SEMINARS IN ONCOLOGY, 2001, 28 (05) :9-18

[6]

ST1571: A paradigm of new agents for cancer therapeutics [J].

Mauro, MJ ;

O'Dwyer, M ;

Heinrich, MC ;

Druker, BJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :325-334

[7]

O'Brien SG, 2001, BLOOD, V98, p141A

← 1 →